Sartorius Stedim Biotech S.A./ADR (SDMHF) registered 50,000,000 American Depositary Shares representing ordinary shares of Sartorius Stedim Biotech S.A. The fee table lists a proposed maximum aggregate price per unit of $0.10 and a proposed maximum aggregate offering price of $5,000,000, estimated solely to calculate the registration fee; the stated fee is $690.50.
The Bank of New York Mellon is the depositary. The registration statement represents that the foreign issuer publishes information contemplated under Rule 12g3-2(b), based on the depositary’s reasonable good-faith belief after limited investigation.
Sartorius Stedim Biotech S.A./ADR registered 50,000,000 American Depositary Shares (ADSs) through JPMorgan Chase Bank, N.A. as depositary; each ADS represents one-tenth of one ordinary share. The fee table lists a proposed maximum price of $0.10 per ADS and a proposed maximum aggregate offering price of $5,000,000, both estimated solely to calculate the registration fee. The deposit agreement describes holder rights, fees, voting and dividend procedures, and deposit and withdrawal restrictions.